IP Library Granted Patent US 8,034,912
Granted Patent B2
US 8,034,912 · App. 12/855,450 · Granted Oct 11, 2011

Parallel preparation of high fidelity probes in an array format

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,912
App. No.
12/855,450
Granted
Oct 11, 2011
Kind
B2
Abstract

The present invention provides massively parallel oligonucleotide synthesis and purification for applications that utilize large collections of defined high-fidelity oligonucleotides (e.g., from about 10 1 to about 10 5 different sequences, generally between 25-160 bases in length).

Claims (29)

1. A method for massively parallel oligonucleotide probe synthesis and release of the synthesized oligonucleotides from an array of probes on a solid substrate, the method comprising:

providing a solid substrate;

attaching a plurality of linkers to the substrate, each linker comprising a cleavable moiety, wherein the cleavable moiety is activatable only at a distinct set of conditions and wherein activation of the cleavable moiety disrupts the linker to allow release of the synthesized oligonucleotides and to provide a substrate with a plurality of attached linkers, wherein the linker has the structure shown below

and wherein PG 1 is protecting group 1, PG 2 is protecting group 2, B is a naturally or non-naturally occurring base, and the linker is attached to the substrate through the 5′-hydroxyl group;

attaching a first monomer to at least one of the plurality of attached linkers to provide an attached first monomer;

attaching a second monomer to a least one of the attached first monomers or the plurality of attached linkers to provide an attached second monomer;

attaching a third monomer to a least one of the attached first monomer, the attached second monomer or the plurality of attached linkers to provide an attached third monomer;

repeating the steps of attaching monomers until the desired array of synthesized oligonucleotides is complete; and

subjecting the array to the distinct set of conditions to activate the cleavable moieties, wherein activation comprises removal of PG 2 , wherein removal of PG 2 allows base-induced intramolecular transesterification, and wherein transesterification releases the synthesized oligonucleotides from the array.

2. The method of claim 1 , wherein the transesterification produces released synthesized oligonucleotides with 3′ hydroxyl groups.

3. The method of claim 1 , wherein the distinct set of conditions comprises an elevated pH level.

4. The method of claim 3 , wherein the elevated pH level is from about 9 to about 12.

5. The method of claim 1 , wherein the distinct set of conditions comprises addition of metal ions.

6. The method of claim 3 , wherein the distinct set of conditions further comprises addition of metal ions.

7. The method of claim 1 , wherein PG 1 is DMT.

8. The method of claim 7 , wherein PG 1 is removed for attachment of the first monomer by exposure to an acid generated by a photoacid generator in the presence of electromagnetic radiation of an appropriate wavelength and in the presence of an acid scavenger.

9. The method of claim 1 , wherein PG 2 is selected from the group consisting of:

Ac, FPMP, CEE, TBDMS, TOM, or a photolabile protecting group.

10. The method of claim 9 , wherein PG 1 is a photolabile protecting group.

11. The method of claim 10 , wherein PG 1 is selected from the group consisting of:

NNPOC or MBPMOC.

12. The method of claim 11 , wherein PG 2 is a photolabile protecting group, and wherein the photolabile protecting group of PG 2 is active at wavelengths longer than 365 nm.

13. The method of claim 1 , wherein PG 1 is a photolabile protecting group.

14. The method of claim 12 , wherein PG 1 is selected from the group consisting of:

NNPOC or MBPMOC.

15. A pool of oligonucleotide probes synthesized according to the method of claim 1 , wherein the pool of oligonucleotide probes comprises oligonucleotides of different monomer sequences.

16. The pool of oligonucleotide probes of claim 15 , wherein the pool comprises oligonucleotides of 100 different sequences.

17. The pool of oligonucleotide probes of claim 16 , wherein the pool comprises oligonucleotides of 100,000 different sequences.

18. The pool of oligonucleotides of claim 15 , wherein the different monomer sequences of the oligonucleotide probes are designed for use as polymerase chain reaction primers for a plurality of target sequences.

Assignments (4)
NOTICE OF RELEASE Recorded Apr 5, 2016
From: BANK OF AMERICA, N.A.
To: AFFYMETRIX, INC.
Reel/Frame 038361/0891 →
RELEASE OF SECURITY INTEREST Recorded Nov 13, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: AFFYMETRIX, INC.
Reel/Frame 037109/0132 →
SECURITY INTEREST Recorded Oct 28, 2015
From: AFFYMETRIX, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036988/0166 →
SECURITY AGREEMENT Recorded Jun 27, 2012
From: AFFYMETRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028465/0541 →